Compression Therapy Market (2025-2032)
The Compression Therapy Market is expected to reach $5.88 billion by 2032, at a CAGR of 3.8% from 2025 to 2032.
- Published
- Jan 2025
- Pages
- 270
- Format
- PDF + Excel
- Report ID
- MRHC - 104957
- Base year
- 2022
- 2032 · FORECAST
- $5.88B
- 2032
- $5.88B
- CAGR 2025–2032
- 3.8%
2022–2024 baseline · 2025–2032 forecast at 3.8% CAGR · hover a bar for the value
Key highlights
By Product: The Garments Segment to Dominate the Compression Therapy Market in 2025
By Technique: The Static Compression Therapy Segment to Dominate the Compression Therapy Market in 2025
By Condition: The Varicose Veins Segment to Dominate the Compression Therapy Market in 2025
By Distribution Channel: The E-commerce Segment to Record the Highest Growth During the Forecast Period
By Facility: The Healthcare Providers Segment to Dominate the Compression Therapy Market in 2025
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | ~270 |
| Format | |
| Forecast Period | 2025–2032 |
| Base Year | 2022 |
| CAGR (Value) | 3.8% |
| Market Size (Value) | USD 5.88 Billion by 2032 |
| Segments Covered | By Product · Bandages · Garments · Stockings · Class I · Class II · Class III · Socks & Sleeves · Wraps & Tapes · Other Garments · Intermittent/Sequential Pneumatic Compression Pumps · Non-segmented Pneumatic Compression Pumps · Segmented Pneumatic Compression Pumps · Other Pressure Pumps · (Note: Other Garments include Inflatable Devices, Liners, Bands, Belts, Braces, and Tubes.) · By Technique · Static Compression Therapy · Dynamic Compression Therapy · By Condition · Varicose Veins · Deep Vein Thrombosis · Lymphedema · Leg Ulcers · Other Conditions · (Note: Other Conditions include Orthostatic Hypotension, Postural Hypotension, Dysautonomia (POTS), Ehlers-Danlos Syndrome (EDS), May-Thurner Syndrome (MTS), and Post-thrombotic Syndrome (PTS).) · By Distribution Channel · Hospitals & Clinics · Pharmacies & Retailers · E-commerce · Other Distribution Channels · (Note: Other Distribution Channels include Nursing Care Centers and Home-care Settings.) · By Facility · Healthcare Providers · Home-care Settings |
| Countries Covered | North America (U.S., Canada), Europe (France, Germany, U.K., Italy, Spain, Switzerland, Netherlands, and Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa |
| Key Companies Profiled | 3M Company (U.S.), Essity Aktiebolag (publ) (Sweden), Bio Compression Systems, Inc. (U.S.), Arjo AB (Sweden), Convatec Inc. (U.S.), Cardinal Health, Inc. (U.S.), PAUL HARTMANN AG (Germany), Medline Industries, Inc. (U.S.), Julius Zorn, Inc. (U.S.), DJO, LLC (U.S.), Smith & Nephew plc (U.K.), medi GmbH & Co. KG (Germany), and SIGVARIS AG (Switzerland) |
Report overview
Segments covered: product. Regions: North America, Europe, Asia-Pacific, Latin America.
The growth of this market is primarily driven by the rising geriatric population, the increasing prevalence of chronic diseases, the growing number of sports injuries and accidents, the growth in orthopedic procedures, the increasing cases of varicose veins and Deep Vein Thrombosis (DVT), the growing acceptance of compression therapy products as a preventive measure, and the minimal side effects and wide-ranging benefits of compression therapy. Furthermore, emerging economies are expected to provide significant growth opportunities for the players operating in this market.
However, the adoption of alternative technologies and an inadequate reimbursement structure for compression therapies are some of the major challenges impacting market growth.
Report infographic
Market dynamics
5 factors across 3 forcesGrowing Demand for Home Care Among the Geriatric Population Driving the Compression Therapy Market
According to the United Nations, the population aged 80 years or over is projected to triple, from 143 million in 2019 to 426 million in 2050.
With the rapid growth in the global geriatric population, cases of age-related chronic diseases are expected to increase globally. This demographic shift is leading to the increased prevalence of various chronic diseases. The prevalence of chronic diseases in the geriatric population is 64/1,000 persons. As per data from UCLA Health, in 2022, there were over 1 billion obese individuals worldwide, comprising 650 million adults, 340 million adolescents, and 39 million children. Furthermore, according to the Biomedical Journal published by Elsevier B.V., varicose veins are highly prevalent, affecting anywhere from 2% to 56% of adults globally. Additionally, approximately 40-50% of women over 45 are affected by varicose veins, and moderately overweight women face a 50% higher risk of developing varicose veins than their non-overweight counterparts.
Compression therapy products effectively treat such diseases by increasing blood pressure in the affected area. Additionally, these products are an effective solution for elderly individuals who may find it challenging to visit hospitals regularly. These products are easily accessible at pharmacies and retailers and widely available on E-commerce platforms. Thus, they eliminate the need for frequent hospital visits, proving highly beneficial for geriatric individuals.
Minimal Side Effects & Wide-ranging Benefits of Compression Therapy Driving Market Growth
Extended hospital stays and surgeries for issues related to the body’s extremities can lead to venous problems like deep vein thrombosis, spider veins, and varicose veins. Furthermore, post-operative complications may result in the formation of blood clots in veins. Compression therapy plays a crucial role in addressing these challenges by promoting faster and more efficient blood flow in the correct direction. This therapy effectively reduces discomfort and swelling, particularly among varicose veins patients. It also alleviates symptoms associated with leg ulcers, such as pain, swelling, and itching. These benefits drive the adoption of compression therapy.
Compression therapy products do not require specialized therapists. For instance, Tactile Medical introduced the FLEXITOUCH PLUS advanced model, extending clinic-based therapy with automated self-manual lymphatic drainage for home use. This solution effectively reduces swelling, fibrosis, and the risk of infection and helps in the treatment of lymphedema and venous disorders. These advantages of compression therapy and market players’ focus on technological advancements to enhance treatment outcomes are increasing the adoption of compression therapy, driving the market’s growth.
Rising Number of Orthopedic Procedures Driving the Compression Therapy Market
Orthopedic procedures are dedicated to the treatment, diagnosis, and repair of the musculoskeletal system and are performed in hospitals and orthopedic centers. These procedures cover joint, bone, ligament, muscle, tendon, and nerve injuries, disorders, and diseases. According to Definitive Healthcare, LLC. (U.S.), from 2018 to 2022, there was a 304% increase in knee replacement claims in ambulatory surgical settings in the U.S. Also, approximately 200 knee replacements per 100,000 inhabitants are performed in Finland and Germany (Source: European Commission, Directorate General for Communication). Thus, the increasing number of orthopedic procedures is driving the compression therapy market.
Table of contents
13 chapters · 114 sections · 270 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Product | Garments | Bandages |
| By Technique | Static Compression Therapy | — |
| By Condition | Varicose Veins | — |
| By Distribution Channel | — | E-commerce |
| By Facility | Healthcare Providers | — |
By Product
- The Garments Segment to Dominate the Compression Therapy Market in 2025
- The garments segment is expected to account for the largest share of 41% of the compression therapy market.
- The segment’s significant market share is attributed to the increasing global geriatric population, which is highly susceptible to improper blood flow, edema, and vein problems like varicose veins, spider veins, and leg ulcers.
- Additionally, the increased demand for compression therapy garments among healthcare professionals and the general population for long-term treatment options contributes to the segment’s large market share.
- However, the bandages segment is projected to record the highest growth rate of 5.9% during the forecast period 2025–2032.
- The high growth of this segment is driven by the use of compression bandages to improve chronic and acute recovery, mitigate fatigue responses, and improve physical performance.
By Technique
- The static compression therapy segment is expected to account for the larger share of the compression therapy market.
- The segment’s large share is attributed to the widespread adoption of static compression therapy due to its benefits, including enhanced comfort during extended use, cost-effectiveness, user-friendly application, and the reliable delivery of consistent pressure.
- However, the dynamic compression therapy segment is projected to record the higher growth rate of 6.3% during the forecast period 2025–2032.
- This growth is driven by the advantages of dynamic compression therapy, such as increased supply and circulation of fresh and oxygenated blood, prevention of fluid accumulation, and reduced swelling in recovering muscles.
By Condition
- The Varicose Veins Segment to Dominate the Compression Therapy Market in 2025
- The varicose veins segment is expected to account for the largest share of the compression therapy market.
- The segment’s large share is attributed to the rising geriatric population prone to vein-related disorders and the increase in secondary disorders associated with vein issues, such as age-related degeneration, hypertension, and obesity.
- Increasing cases of venous thromboembolism and blood clot formation are expected to further drive the demand for compression therapy products.
- For instance, there are approximately 10 million cases of Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) globally each year, with approximately one million cases in the U.S. and nearly 700,000 in Italy, France, Sweden, Germany, Spain, and the U.K. combined.
By Distribution Channel
- The E-commerce Segment to Record the Highest Growth During the Forecast Period
- The E-commerce segment is expected to register the highest CAGR during the forecast period 2025–2032.
- The segment’s high growth is driven by the increased availability of medical supplies at lower prices through E-commerce platforms, as well as the rising popularity of these platforms due to the benefits offered.
By Facility
- The healthcare providers segment is expected to account for the larger share of the compression therapy market.
- The segment’s large share is attributed to healthcare providers’ increasing recommendation to use compression therapy solutions for people at risk of deep vein thrombosis and obesity, and the use of compression solutions in the management of chronic venous insufficiency.
Geographic analysis
North America
Largest shareIn 2025, North America is expected to account for the largest share of 30.8% of the compression therapy market, followed by Europe and Asia-Pacific. In North America, the U.S. is expected to account for the largest market share in 2025. The significant market share of the U.S. can be attributed to several key factors, including increased awareness regarding the benefits and convenience of compression therapy, the presence of key market players, and the country’s technologically advanced healthcare environment and robust healthcare infrastructure.
Asia-Pacific
Fastest growthHowever, Asia-Pacific is slated to register the highest growth rate during the forecast period due to growing markets such as India (CAGR 5.9%) and China (CAGR 6.1%). The high growth of the APAC compression therapy market is driven by the increased number of acute injuries and accidents, the rising geriatric population, growing healthcare expenditures, and key market players’ focus on expanding their presence in the region.
Competitive landscape
- February 2025
Homedics USA (U.S.), a subsidiary of FKA Distributing Co., LLC. (U.S.), launched the Modulair Compression System, a customizable compression massage system targeting the calf, wrist, knee, and foot.
- September 2025
AIROS Medical, Inc. (U.S.) launched pants-like compression garments and the AIROS 6P sequential compression device for the treatment of pelvic, leg, and abdominal swelling.
- April 2025
AIROS Medical, Inc. (U.S.) received U.S. FDA approval for its AIROS 8P Sequential Compression Therapy device and garment system. The clearance allowed AIROS to provide its compression therapy garments for the treatment of abdominal swelling.
- June 2022
Hyper Ice, Inc. (U.S.) launched Normatec 3 by Hyperice, which is a compression therapy system that uses dynamic air compression to aid in improved training, faster recovery, and maximized performance. Normatec 3 by Hyperice reduces pain and muscle fatigue and increases the range of motion.
- April 2021
DJO, LLC (U.S.) acquired MedShape, Inc. (U.S.), a company offering shape-memory technologies for foot and ankle surgeries.
- 3M Company (U.S.)
- Essity Aktiebolag (publ) · Sweden
- Bio Compression Systems, Inc. (U.S.)
- Arjo AB · Sweden
- Convatec Inc. (U.S.)
- Cardinal Health, Inc. (U.S.)
- PAUL HARTMANN AG · Germany
- Medline Industries, Inc. (U.S.)
- Julius Zorn, Inc. (U.S.)
- DJO, LLC (U.S.)
- Smith & Nephew plc (U.K.)
Frequently asked questions
This study offers a detailed assessment of the compression therapy market, including the market sizes & forecasts for market segments by product, technique, condition, distribution channel, and facility. The study also provides an in-depth analysis of various segments & subsegments of the compression therapy market at the regional and country levels.
Cite this report
Meticulous Research. (2025). Compression Therapy Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 104957). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/compression-therapy-market-5640